Abstract
The prevalence of chronic kidney disease (CKD) in the United States has increased in the last 20 years. As CKD and cardiovascular disease (CVD) are interrelated, it is important to note that trends in the prevalence of CKD and common risk factors it shares with CVD, such as hypertension and diabetes, are likely to affect the burden of both diseases in the future. While preventing and treating CVD is of high priority in the primary care setting, a major reason why CKD continues to burden the US healthcare system is because it remains under-recognized by primary care physicians and specialists, partly due to a lack of uniform screening recommendations. This paper will review the public health implications of CKD, including its epidemiology and economic burden in the United States, its risk factor commonalities with CVD, current screening recommendations and possible prevention strategies for improvement in the future. Additionally, an emphasis will be made on encouraging primary care physicians to play a more prominent role in CKD screening and primary prevention.
Keywords: Chronic kidney disease, cardiovascular disease, epidemiology, prevention, primary care, public health, screening.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care
Volume: 14 Issue: 3
Author(s): Tarleen K. Singh, Vibhuti Arya and Nishanthika Navaratnarajah
Affiliation:
Keywords: Chronic kidney disease, cardiovascular disease, epidemiology, prevention, primary care, public health, screening.
Abstract: The prevalence of chronic kidney disease (CKD) in the United States has increased in the last 20 years. As CKD and cardiovascular disease (CVD) are interrelated, it is important to note that trends in the prevalence of CKD and common risk factors it shares with CVD, such as hypertension and diabetes, are likely to affect the burden of both diseases in the future. While preventing and treating CVD is of high priority in the primary care setting, a major reason why CKD continues to burden the US healthcare system is because it remains under-recognized by primary care physicians and specialists, partly due to a lack of uniform screening recommendations. This paper will review the public health implications of CKD, including its epidemiology and economic burden in the United States, its risk factor commonalities with CVD, current screening recommendations and possible prevention strategies for improvement in the future. Additionally, an emphasis will be made on encouraging primary care physicians to play a more prominent role in CKD screening and primary prevention.
Export Options
About this article
Cite this article as:
Singh K. Tarleen, Arya Vibhuti and Navaratnarajah Nishanthika, Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care, Cardiovascular & Hematological Disorders-Drug Targets 2014; 14 (3) . https://dx.doi.org/10.2174/1871529X14666140401115110
DOI https://dx.doi.org/10.2174/1871529X14666140401115110 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bariatric Surgery - Effects on Obesity and Related co-Morbidities
Current Diabetes Reviews Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Optimising the Use of Non-Invasive Ventilation in the Intensive Care Setting
Current Respiratory Medicine Reviews Surgery for Severe Obesity: Indications, Techniques, Mechanisms of Weight Loss and Diabetes Resolution
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Heart Failure in East Asia
Current Cardiology Reviews Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research The Role of Prostaglandins in Liver Ischemia-Reperfusion Injury
Current Pharmaceutical Design Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology Nanoparticles Functionalized with Venom-Derived Peptides and Toxins for Pharmaceutical Applications
Current Pharmaceutical Biotechnology Evidence for a Putative Relationship Between Type 2 Diabetes and Neoplasia with Particular Reference to Breast Cancer: Role of Hormones, Growth Factors and Specific Receptors
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Substance P Prevents Vascular Endothelial Dysfunction in Metastatic Breast Carcinoma
Protein & Peptide Letters Nephro-Protective Effect of Cortex Lycii Radicis Extracts in Streptozotocin- Induced Diabetic Rats
Current Signal Transduction Therapy The Important Role of Potatoes, An Underrated Vegetable Food Crop in Human Health and Nutrition
Current Nutrition & Food Science The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
Current Diabetes Reviews Antihypertensive Therapy: Role of Aldosterone Antagonists
Current Pharmaceutical Design Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Sleep-Related Disorders, Diabetes and Obesity: Understanding the Facts
Current Respiratory Medicine Reviews